Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer

被引：16
|
作者：
Melosky, Barbara [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver Ctr, Med Oncol, 600 West 10th Ave, Vancouver, BC V5Z 4E6, Canada
来源：
FRONTIERS IN ONCOLOGY | 2014年 / 4卷
关键词：
metatstatic non-squamous NSCLC; systemic therapy; chemotherapy; targeted therapy;
D O I：
10.3389/fonc.2014.00256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A number of developments have altered the treatment paradigm for metastatic non-small cell, non-squamous lung cancer. These include increasing knowledge of molecular signal pathways, as well as the outcomes of several large-scale trials. As a result, treatments are becoming more efficacious and more personalized, and are changing the management and prognosis of non-small cell lung cancer patients. This is resulting in increased survival in select patient groups. In this paper, a simplified algorithm for treating patients with metastatic non-small cell, non-squamous lung cancer is presented.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation
    Akerley, Wallace
    Boucher, Kenneth
    Rich, Nathan
    Egbert, Lyle
    Harker, Graydon
    Bylund, Julie
    Van Duren, Terry
    Reddy, Chakravarthy
    [J]. LUNG CANCER, 2013, 79 (03) : 307 - 311
  • [42] Non-squamous, metastatic non-small cell lung cancer: Retrospective c-met overexpression testing, patient characteristics, and treatment patterns
    Cai, Mona H.
    Choi, Yookyung Christy
    Vasilopoulos, Athan
    Liede, Alexander
    Lindsey, Sidney
    Raskin, Leon
    Truong, Ethan
    Fricke, Jeremy
    Gruber, Stephen
    Ansell, Peter
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 429 - 429
  • [43] Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence
    Lim, Joline S. J.
    Soo, Ross A.
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (05) : 444 - 454
  • [44] A Phase I Study of Exemestane with Carboplatin and Pemetrexed in Postmenopausal Women with Metastatic, Non-Squamous Non-Small Cell Lung Cancer
    Pietras, Richard
    Goldman, Jonathan W.
    Marquez-Garban, Diana C.
    Wong, Deborah J. L.
    Applebaum, Steven
    Mendenhall, Melody
    Ledezma, Blanca A.
    Wolf, Brian
    Adame, Carlos R.
    Rosales, Sarah
    Paroly, Jill
    Paiz, Sebastian
    Nameth, Danielle
    Spiegel, Marshall L.
    Hecht, Naomi
    Brennan, Meghan
    Dubinett, Steven M.
    Garon, Edward B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S667 - S667
  • [45] Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients
    Gilden, Daniel M.
    Kubisiak, Joanna M.
    Pohl, Gerhardt M.
    Ball, Daniel E.
    Gilden, David E.
    John, William J.
    Wetmore, Stewart
    Winfree, Katherine B.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (02) : 151 - 161
  • [46] The impact of population-based EGFR testing in non-squamous metastatic non-small cell lung cancer in Alberta, Canada
    Brenner, Darren R.
    O'Sullivan, Dylan E.
    Jarada, Tamer N.
    Yusuf, Amman
    Boyne, Devon J.
    Mather, Cheryl A.
    Box, Adrian
    Morris, Donald G.
    Cheung, Winson Y.
    Mirza, Imran
    [J]. LUNG CANCER, 2023, 175 : 60 - 67
  • [47] Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer
    Hirai, Fumihiko
    Seto, Takashi
    Inamasu, Eiko
    Shimokawa, Mototsugu
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Nosaki, Kaname
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    [J]. ONCOLOGY LETTERS, 2015, 9 (06) : 2577 - 2582
  • [48] COST EFFECTIVENESS OF PEMETREXED/CISPLATIN (PEM/CIS) IN THE TREATMENT OF ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSQNSCLC) PATIENTS
    Winfree, K. B.
    Shah, M.
    Peterson, P.
    Gruschkus, S.
    Eaddy, M.
    Green, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 428 - 428
  • [49] Clinical Study of Pemetrexed as the First-line Treatment in Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Pu Xiaolin
    Wang Jun
    Li Wei
    Lu Binbin
    Wang Zhaoxia
    Yang Min
    Fan Weifei
    [J]. JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (04): : 205 - 209
  • [50] Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid
    Kwok, Wang Chun
    Cheong, Tan Fong
    Chiang, Ka Yan
    Ho, James Chung Man
    Lam, David Chi Leung
    Ip, Mary Sau Man
    Tam, Terence Chi Chun
    [J]. LUNG CANCER, 2021, 152 : 15 - 20
12345